<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Mon, 09 Nov 2009 04:18:04 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Biostar Raises $3.6 Million</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</guid>
      <description><![CDATA[Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614366>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 17:26:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BSPM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614366</link>
    </item>
    <item>
      <title>Bulls Back On Track?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</guid>
      <description><![CDATA[Good morning. With chants of &quot;Dow 10K… Dow 10K&quot; once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614255>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 16:21:18 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614255</link>
    </item>
    <item>
      <title>Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</guid>
      <description><![CDATA[Ford's 2,215 page 2007 master contract with the UAW 
1941 UAW-Ford contract<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614051>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 13:52:50 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614051</link>
    </item>
    <item>
      <title>Your Kind of Day?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</guid>
      <description><![CDATA[As a rule, I try not to read too terribly much into a &quot;Fed Day&quot; as there is usually a big batch of volatility that may or may not mean much of anything come the dawn of the next day. Maybe, it's just me. Or maybe there are others that find themselves inclined to simply stand aside and watch the nuttiness from the sidelines on &quot;Fed Days.&quot; But in any event, the volatility after a Fed announcement, while fun to watch, may not be telling as to what to expect in the future.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611831>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 19:06:48 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TGT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611831</link>
    </item>
    <item>
      <title>The Dollar-Proof Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</guid>
      <description><![CDATA[Don't put off this important piece of the financial-planning process.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3611744>[More...]</a>]]></description>
      <pubDate>Thu, 05 Nov 2009 17:31:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CEW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IEO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MON</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STPZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VEU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VSS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VTI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WIP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3611744</link>
    </item>
    <item>
      <title>What Investors Should Look for In Today’s Fed Statement</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3605772</guid>
      <description><![CDATA[In its continuing efforts to nurture the fragile economic recovery, the U.S. Federal Reserve is widely expected to leave interest rates at record lows when it concludes its meeting today (Wednesday).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3605772>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 13:04:24 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BCS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ING</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3605772</link>
    </item>
    <item>
      <title>Are Discount Brokers Shares Worth Owning?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3604683</guid>
      <description><![CDATA[The third quarter was a favorable one for the longs. Except for a few short-lived, minor pullbacks stock prices moved higher through the quarter. Stock price volatility declined, takeover activity rose, and risk appetite improved to help the S&amp;P gain 15%.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3604683>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 01:28:03 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMTD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ETFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SCHB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3604683</link>
    </item>
    <item>
      <title>Technology Rises And Buying Facebook</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601987</guid>
      <description><![CDATA[Technology stocks have done well this year. The Technology Select Sector SPDR (XLK) bottomed out in March and by late October was up more than 60%.&#160;&#160; Tech has performed better than any other sector year-to-date – up 33.7% as of Friday’s close.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601987>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 16:54:11 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601987</link>
    </item>
    <item>
      <title>Buffett Gets His Cheque Book Out</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601899</guid>
      <description><![CDATA[Given the slew of positive economic data Monday you might have been forgiven for expecting a decent rebound in risk assets. There was a rebound of sorts in early New York trading, with the Dow up close to 150 points at one stage.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601899>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 16:17:34 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">F</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601899</link>
    </item>
    <item>
      <title>Five Ways To Ride The Commodities Bull</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3601726</guid>
      <description><![CDATA[Commodity prices have faltered in the last couple of weeks, and much of the “smart money” is saying the boom is over.
Don’t believe it.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3601726>[More...]</a>]]></description>
      <pubDate>Tue, 03 Nov 2009 15:21:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">VALE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3601726</link>
    </item>
    <item>
      <title>Beware, Many Stolen Computers Have Tracking Software</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3579078</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 26--LAWRENCE -- At $250, the laptop computer purchased on the street appeared to be a good deal. &lt;/li&gt;&lt;li&gt;But when officers showed up at Aileen Acevedo's Brook Street home with a search warrant seeking the computer a few nights later, she learned it was stolen from Lahey Clinic in Burlington, police said. &lt;/li&gt;&lt;li&gt;As with most computers being manufactured now, the Fujitsu Tablet laptop was equipped with tracking software which can pinpoint a stolen computer to any address.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3579078>[More...]</a>]]></description>
      <pubDate>Mon, 26 Oct 2009 14:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BBY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3579078</link>
    </item>
    <item>
      <title>Boston Scientific returns to profit in 3rd qtr</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3562936</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NATICK, Mass - Medical device maker Boston Scientific Corp. returned to a profit in the third quarter, reporting Monday that sales of its heart-shocking implants held up in spite of hospital cutbacks squeezing its competitors.&lt;/li&gt;&lt;li&gt;Boston Scientific said sales for the third quarter rose 3 percent to $2.03 billion on higher revenue for implantable cardiac defibrillators, which control irregular heart rhythms.&lt;/li&gt;&lt;li&gt;Rival company St. Jude Medical recently reported a decline in sales of the cardiac devices to hospitals.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3562936>[More...]</a>]]></description>
      <pubDate>Mon, 19 Oct 2009 23:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BSX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STJ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3562936</link>
    </item>
    <item>
      <title>Sliding Dollar May Be Something to Cheer About</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3557369</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;WASHINGTON _ The falling dollar is stoking fears of inflation and worries about the country's eroding power in the world. &lt;/li&gt;&lt;li&gt;But for now it may be just the tonic that's needed to help the U.S. economy get back on its feet.&lt;/li&gt;&lt;li&gt;By making American products cheaper for most foreign buyers, the dollar is helping many U.S. companies boost their overseas sales.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3557369>[More...]</a>]]></description>
      <pubDate>Fri, 16 Oct 2009 17:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3557369</link>
    </item>
    <item>
      <title>Abbott Reports Earnings Gain on Stronger Sales, Settlement of Patent Suit: W.W. Grainger Reports Revenue Continues to Fall</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3553147</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 15--Abbott Laboratories reported its third-quarter profit jumped nearly 37 percent thanks to a patent settlement and ongoing sales improvement in its drug and medical-device businesses. &lt;/li&gt;&lt;li&gt;Excluding one-time costs, Abbott earned 92 cents per share, 2 cents above Wall Street analysts' estimates. &lt;/li&gt;&lt;li&gt;Abbott said sales of its blockbuster rheumatoid arthritis drug Humira, which also treats other autoimmune disorders, were up nearly 24 percent worldwide, to $1.5 billion.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3553147>[More...]</a>]]></description>
      <pubDate>Thu, 15 Oct 2009 09:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACAS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GWW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3553147</link>
    </item>
    <item>
      <title>Abbott Profit Up 37% on Patent Settlement, Humira Sales</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3551927</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 14--Abbott Laboratories reported third-quarter profit jumped nearly 37 percent thanks to a patent settlement in the period and ongoing sales improvement in its drug and medical device businesses. &lt;/li&gt;&lt;li&gt;The company said those sales were ahead of analyst expectations. &lt;/li&gt;&lt;li&gt;&quot;Abbott is performing well, generating higher-than-expected earnings growth in the third quarter,&quot; Abbott chairman and chief executive officer Miles White said in a statement issued early this morning.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3551927>[More...]</a>]]></description>
      <pubDate>Wed, 14 Oct 2009 19:06:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3551927</link>
    </item>
    <item>
      <title>Humira and nutrition sales lift Abbott 3Q profit</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3550727</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NORTH CHICAGO, Ill. - Abbott Laboratories said Wednesday it beat its own expectations for the third quarter as sales of its drug Humira continued to climb, along with sales of medical products and nutritional formula for children.&lt;/li&gt;&lt;li&gt;The better-than-expected results for its lead product sent Abbott shares higher in morning trading as the company raised its earnings outlook for the year. &lt;/li&gt;&lt;li&gt;For the quarter, Abbott's profit rose 16 percent, to $1.43 billion, or 95 cents per share, from $1.24 billion, or 79 cents per share.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3550727>[More...]</a>]]></description>
      <pubDate>Wed, 14 Oct 2009 16:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3550727</link>
    </item>
    <item>
      <title>St. Louis Post-Dispatch, David Nicklaus Column</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3529117</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 4--If the stock market's bulls are to have anything more than a  brief romp, companies will have to start making money pretty soon. &lt;/li&gt;&lt;li&gt;When the companies in the Standard and Poor's 500 tally their results  for this year's third quarter, analysts expect to see a 25 percent profit  drop. &lt;/li&gt;&lt;li&gt;It would be the ninth straight quarter of falling earnings, the longest  such streak since Thomson Reuters began keeping track in 1998.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3529117>[More...]</a>]]></description>
      <pubDate>Sun, 04 Oct 2009 19:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XRX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3529117</link>
    </item>
    <item>
      <title>Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3515948</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Sep. 30--As Wyeth's acquisition by Pfizer Inc. took one step closer to completion yesterday, state legislators spearheading efforts to retain jobs here said they were fairly confident many positions would remain at Wyeth's regional operations. &lt;/li&gt;&lt;li&gt;&quot;Representatives of both Pfizer and Wyeth have continued to assure us that we should not worry and they have continued to listen to the case that we have made for as many jobs as possible remaining in Pennsylvania,&quot; said State Sen. Andy Dinniman, a Democrat who represents parts of Chester and Montgomery Counties. &lt;/li&gt;&lt;li&gt;Wyeth employs about 4,500 people in the region -- about 3,600 in Collegeville and 900 in Great Valley and other sites.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3515948>[More...]</a>]]></description>
      <pubDate>Wed, 30 Sep 2009 17:12:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRXL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3515948</link>
    </item>
    <item>
      <title>Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3515121</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Sep. 30--As Wyeth's acquisition by Pfizer Inc. took one step closer to completion yesterday, state legislators spearheading efforts to retain jobs here said they were fairly confident many positions would remain at Wyeth's regional operations. &lt;/li&gt;&lt;li&gt;&quot;Representatives of both Pfizer and Wyeth have continued to assure us that we should not worry and they have continued to listen to the case that we have made for as many jobs as possible remaining in Pennsylvania,&quot; said State Sen. Andy Dinniman, a Democrat who represents parts of Chester and Montgomery Counties. &lt;/li&gt;&lt;li&gt;Wyeth employs about 4,500 people in the region -- about 3,600 in Collegeville and 900 in Great Valley and other sites.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3515121>[More...]</a>]]></description>
      <pubDate>Wed, 30 Sep 2009 10:08:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRXL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3515121</link>
    </item>
    <item>
      <title>BosSci Paying $716M to J&amp;J: Action Resolves Some, but Not All, Heart Stent Suits</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3514984</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Sep. 30--Boston Scientific will pay $716 million to medical products giant Johnson &amp; Johnson to settle more than a dozen lawsuits related to patents for heart stents. &lt;/li&gt;&lt;li&gt;Stents are metal mesh tubes used to prop open heart arteries, and Natick, Mass.-based Boston Scientific makes the products at a division based in Maple Grove. &lt;/li&gt;&lt;li&gt;While the settlement announced Tuesday resolves 14 lawsuits between the companies, other patent disputes continue.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3514984>[More...]</a>]]></description>
      <pubDate>Wed, 30 Sep 2009 08:08:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BSX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WWY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3514984</link>
    </item>
    <item>
      <title>Maguire Properties Reports Third Quarter 2009 Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3599408</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;MaguireProperties, Inc. (NYSE: MPG), a SouthernCalifornia-focused real   estate investment trust reported results for the quarter ended   September30,2009.&lt;/li&gt;&lt;li&gt;During the   third quarter, we accrued default interest totaling $4.6million as   well as regular scheduled interest totaling $7.3 million related to   properties currently in default, both of which are unpaid as of   September 30, 2009.&lt;/li&gt;&lt;li&gt;Net loss available to common stockholders for the quarter ended   September30,2009 was $(46.8)million, or $(0.97) per share, compared   to a net loss available to common stockholders of $(72.5)million, or   $(1.52) per share, for the quarter ended September30,2008.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3599408>[More...]</a>]]></description>
      <pubDate>Mon, 02 Nov 2009 20:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MPG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3599408</link>
    </item>
    <item>
      <title>Impax Laboratories Confirms Patent Challenge Relating to TRICOR&amp;#174; 48mg and 145mg Tablets</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3593490</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Impax Laboratories, Inc. (NASDAQ:IPXL) today confirms that   it has initiated a challenge of the patents listed by Abbott   Laboratories in connection with its TRICOR&amp;#174; (fenofibrate) tablets, 48 mg   and 145 mg.&lt;/li&gt;&lt;li&gt;Impax filed its Abbreviated New Drug Application (&quot;ANDA&quot;) containing a   Paragraph IV certification for a generic version of TRICOR&amp;#174; with the   U.S. Food &amp; Drug Administration (&quot;FDA&quot;). &lt;/li&gt;&lt;li&gt;Following receipt of the notice   from the FDA that Impax's ANDA had been accepted for filing, Impax   notified the New Drug Application holder and patent owners of its   Paragraph IV certification.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3593490>[More...]</a>]]></description>
      <pubDate>Fri, 30 Oct 2009 14:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IPXL</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3593490</link>
    </item>
    <item>
      <title>Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3560797</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;New U.S. and Foreign Patents&lt;/li&gt;&lt;li&gt;The United States Patent and Trademark Office (USPTO) issued a patent to   HDC that includes additional, broader claims to the Company's exclusive   Recursive Feature Elimination (RFE) using Support Vector Machines   (&quot;SVM&quot;) or SVM-RFE method, the first patent for which issued in 2006.   &lt;/li&gt;&lt;li&gt;The European Patent Office issued a notice of its intent to grant a   patent covering HDC's SVM-based computer-aided image analysis   techniques.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3560797>[More...]</a>]]></description>
      <pubDate>Mon, 19 Oct 2009 13:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CLRT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DGX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HDVY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IART</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3560797</link>
    </item>
    <item>
      <title>PicksThatMove.Com Announces Investment Opinion Hot Stocks on NVNC, MPG, ACOR, KNA and ROYL</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3557061</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;PicksThatMove is pleased to bring investors special situation stocks   which have a high potential for price appreciation. &lt;/li&gt;&lt;li&gt;Today's hot stocks to watch include: Novo Energies Corp. (OTCBB:NVNC),   Maguire Properties Inc. (NYSE:MPG), Acorda Therapeutics Inc.   (NASDAQ:ACOR), Keystone North America (TSX: KNA) and Royale Energy Inc.   (NASDAQ: ROYL).&lt;/li&gt;&lt;li&gt;Novo Energies Corp. (OTCBB: NVNC), +$0.02, 2.56%, $0.80, operates in the   renewable energy sector developing cost effective technology which   converts plastic and tire waste into liquid fuels.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3557061>[More...]</a>]]></description>
      <pubDate>Fri, 16 Oct 2009 15:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACOR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MPG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVNC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROYL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3557061</link>
    </item>
    <item>
      <title>RidgewaterEquity.Com Free Fundamental Sector &amp;Amp; Market Research on MPG, NTT, ASX, NM, BRE and GPI</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3518935</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;RidgewaterEquity.com inspires to bring the best from the internet under one roof, providing you with a one click option to view what the market, researchers and financial pundits worldwide have to say about any particular large cap stocks in any given financial environment. &lt;/li&gt;&lt;li&gt;Once you sign up as a free member you will have free unlimited access to all our reports, research tools and more.&lt;/li&gt;&lt;li&gt;We have recently begun in-depth analysis of the following equities &amp;amp; their respective sectors:&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3518935>[More...]</a>]]></description>
      <pubDate>Thu, 01 Oct 2009 11:07:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ASX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BRE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GPI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MPG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NTT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3518935</link>
    </item>
    <item>
      <title>AMB Property Corporation(R) Leases 178,000 SF in Guadalajara Development</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3472097</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;SAN FRANCISCO, Sept. 10  /PRNewswire-FirstCall/ -- AMB Property Corporation , a leading global owner, operator and developer of industrial real estate, today announced it has leased approximately 178,000 square feet (16,500 square meters) of its AMB Los Altos Building 2 development in Guadalajara, Mexico to Summa Company, a food distribution and sales company.&lt;/li&gt;&lt;li&gt;&quot;Guadalajara's diverse industrial base and population density makes this a dynamic market and lends strength to the area,&quot; said Luis Gutierrez, AMB's managing director, Mexico. &lt;/li&gt;&lt;li&gt;&quot;Summa Company required new distribution space in Guadalajara to accommodate its growth, and AMB provided the ideal solution because of their in-depth understanding of logistics real estate.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3472097>[More...]</a>]]></description>
      <pubDate>Thu, 10 Sep 2009 20:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3472097</link>
    </item>
    <item>
      <title>AMB Property Corporation(R) Leases 65,000 SF in Paris Development</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3450456</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;SAN FRANCISCO, Sept. 1  /PRNewswire-FirstCall/ -- AMB Property Corporation  , a leading global owner, operator and developer of industrial real estate, today announced it has leased approximately 65,000 square feet (6,000 square meters) in AMB Port of Rouen, a development in its Paris market, which is now fully leased. &lt;/li&gt;&lt;li&gt;This new lease with Lincoln Electric, a leading manufacturer of welding equipment, in conjunction with the previously announced 210,000 square feet (19,500 square meters) of leasing to Schenker France and Necotrans, brings the 275,000 square foot (25,500 square meter) project to 100 percent leased a month before completion of development.&lt;/li&gt;&lt;li&gt;The Port of Rouen occupies a strategic position within France and provides rapid access to major economic centers in the region through a vast highway network, a dense railway system and two major airports, Roissy and Orly.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3450456>[More...]</a>]]></description>
      <pubDate>Tue, 01 Sep 2009 21:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LECO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3450456</link>
    </item>
    <item>
      <title>McKenna Long &amp; Aldridge LLP Consolidates Offices in Downtown Los Angeles</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3446808</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;International law firm McKenna Long &amp; Aldridge LLP (MLA) has signed a   long term lease with Maguire Properties to occupy 62,418 square feet at   One California Plaza in downtown Los Angeles. &lt;/li&gt;&lt;li&gt;The new lease enables the law firm to   consolidate its Los Angeles attorneys, who currently work out of two   downtown locations, into a single location.&lt;/li&gt;&lt;li&gt;&quot;Our Los Angeles office has the region's leading Government Contracts   practice as well as a very strong Real Estate group, so it is ideally   placed to help clients navigate the business opportunities and   challenges associated with the stimulus package as well as potential   public-private partnerships for infrastructure development,&quot; said Thomas   Abbott, chair of MLA's Government Contracts practice.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3446808>[More...]</a>]]></description>
      <pubDate>Mon, 31 Aug 2009 17:53:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MPG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3446808</link>
    </item>
    <item>
      <title>Strategic Hotels &amp; Resorts Appoints Raymond L. Gellein, Jr. and Eugene F. Reilly as New Independent Directors</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3443140</guid>
      <description><![CDATA[Strategic Hotels &amp; Resorts, Inc. , has appointed Raymond L. 'Rip' Gellein, Jr. and Eugene F. Reilly as independent members of the Board of Directors. With the appointment of Mssrs. Gellein and Reilly, the Company's Board of Directors has nine members.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3443140>[More...]</a>]]></description>
      <pubDate>Thu, 27 Aug 2009 21:05:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BEE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3443140</link>
    </item>
    <item>
      <title>Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3443157</guid>
      <description><![CDATA[Abbott announced today that it has entered into an agreement with Pfizer Inc to develop a molecular diagnostic test intended to screen non-small cell lung cancer tumors for the presence of gene rearrangements. Pfizer has developed a novel investigational agent that selectively targets cancer-causing genes implicated in the progress of many cancers. To be eligible to receive Pfizer's oral therapy, a particular genetic translocation known to be found in NSCLC tumors and a wide variety of other cancers, but not in normal cells, must be present.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3443157>[More...]</a>]]></description>
      <pubDate>Thu, 27 Aug 2009 12:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3443157</link>
    </item>
    <item>
      <title>Form  4          ABBOTT LABORATORIES       For: Nov 02  Filed by: ALBAN CARLOS (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608085</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608085>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:44:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608085</link>
    </item>
    <item>
      <title>Form  4          ABBOTT LABORATORIES       For: Nov 02  Filed by: Mason Heather L (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608077</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608077>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608077</link>
    </item>
    <item>
      <title>Form  4          ABBOTT LABORATORIES       For: Oct 20  Filed by: Warmuth Michael J (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3573564</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3573564>[More...]</a>]]></description>
      <pubDate>Thu, 22 Oct 2009 22:45:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3573564</link>
    </item>
    <item>
      <title>Form  4          ABBOTT LABORATORIES       For: Oct 20  Filed by: Fussell Stephen R (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3573561</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3573561>[More...]</a>]]></description>
      <pubDate>Thu, 22 Oct 2009 22:44:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3573561</link>
    </item>
    <item>
      <title>Form  4          ABBOTT LABORATORIES       For: Oct 20  Filed by: ROBERTS ROY S (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3573560</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3573560>[More...]</a>]]></description>
      <pubDate>Thu, 22 Oct 2009 22:43:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3573560</link>
    </item>
    <item>
      <title>Form  4          ABBOTT LABORATORIES       For: Oct 16  Filed by: Patton Donald V JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3566657</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3566657>[More...]</a>]]></description>
      <pubDate>Tue, 20 Oct 2009 23:43:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3566657</link>
    </item>
    <item>
      <title>Form  4          ABBOTT LABORATORIES       For: Oct 16  Filed by: Warmuth Michael J (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3566653</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3566653>[More...]</a>]]></description>
      <pubDate>Tue, 20 Oct 2009 23:41:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3566653</link>
    </item>
    <item>
      <title>Form  4          ABBOTT LABORATORIES       For: Oct 15  Filed by: ALBAN CARLOS (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3562849</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3562849>[More...]</a>]]></description>
      <pubDate>Mon, 19 Oct 2009 22:55:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3562849</link>
    </item>
    <item>
      <title>Form  3          ABBOTT LABORATORIES       For: Oct 15  Filed by: ALBAN CARLOS (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3562820</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3562820>[More...]</a>]]></description>
      <pubDate>Mon, 19 Oct 2009 22:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3562820</link>
    </item>
    <item>
      <title>Form  4/A        RISING NELSON C           For: May 17 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3525134</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3525134>[More...]</a>]]></description>
      <pubDate>Fri, 02 Oct 2009 22:57:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MPG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3525134</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=ABT,AMB,EGLS,EMAG,MPG,SAY," rel="self" type="application/rss+xml" />
  </channel>
</rss>